1. Juárez-Salcedo LM, Castillo JJ. Lymphoplasmacytic lymphoma and marginal zone lymphoma. Hematol Oncol Clin North Am 2019;33:639-656.  

2. Yu X, Li W, Deng Q, et al. MYD88 L265P mutation in lymphoid malignancies. Cancer Res 2018;78:2457-2462.  

3. Walsh NM, Kutzner H, Requena L, et al. Plasmacytic cutaneous pathology: A review. J Cutan Pathol 2019;46:698-708.  

4. Liu Y-C, Liu Y, Knowles DM, et al. Aberrantly sustained PAX5 expression in plasma cell differentiation is a frequent feature in lymphoplasmacytic lymphoma but not marginal zone lymphoma in bone marrow. J Hematop 2013;6:169-177.  

5. Plaza JA, Comfere NI, Gibson LE, et al. Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia. J Am Acad Dermatol 2009;60:772-780.  

6. Bassarova A, Trøen G, Spetalen S, et al. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature. Blood 2014;124:5399.  

7. Goodlad, J, Calonje, JE. Cutaneous lymphoproliferative diseases and related disorders. In Calonje JE, Brenn T, Lazar A, et al. McKee’s Pathology of the Skin. Edinburgh: Elsevier/Saunders; 2011. p. 1311-1420.  

8. Cory S, Huang DCS, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003;22:8590-8607.  

9.  Tadmor T, Tiacci E, Falini B, Polliack A. The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis. Leuk Lymphoma 2012;53:2339-2340.  

10. Vaqué JP, Martínez N, Batlle-López A, et al. B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies. Haematologica 2014;99:222-231.

     

Acknowledgements

Author Profiles

Catherine Baker

Geisel School of Medicine at Dartmouth

Catherine Baker is a fourth-year medical student at the Geisel School of Medicine at Dartmouth. She is interested in dermatology and has particular interest in cutaneous malignancies. She will be applying to dermatology residency this year

Aravindhan Sriharan

Geisel School of Medicine at Dartmouth

Aravindhan Sriharan, MD, is a staff dermatopathologist at Dartmouth-Hitchcock Medical Center, and assistant professor of pathology and laboratory medicine at the Geisel School of Medicine at Dartmouth. He completed his undergraduate studies at Columbia University in New York City and went to medical school at the University of Tennessee Health Sciences Center. He then completed his residency training in pathology at the Orlando Regional Medical Center and dermatopathology fellowship training at the University of Pittsburgh Medical Center. His professional interests include the pathogenesis and genomic features of melanocytic neoplasms. His research, not related to the submitted case study, is funded in part by a grant from the Hitchcock Foundation.